期刊文献+

雷贝拉唑与不同抗生素联用序贯治疗幽门螺杆菌的疗效观察 被引量:9

Efficacy Observation of Sequential Treatment with Rabeprazole Combined with Different Antibiotic on Helicobacter Pylori Infection
原文传递
导出
摘要 目的:观察雷贝拉唑与不同抗生素联用序贯治疗幽门螺杆菌(Hp)的临床疗效。方法:将14C-尿素呼气试验确诊为Hp感染且胃镜证实为消化性溃疡或慢性胃炎的186例患者随机均分为观察组与对照组,观察组给予雷贝拉唑+四环素+克拉霉素连用5d,继以雷贝拉唑+呋喃唑酮+左氧氟沙星连用5d;对照组予雷贝拉唑+阿莫西林+克拉霉素连用10d。疗程结束4周后复查14C-尿素呼气试验。结果:观察组与对照组Hp根治率分别为93.5%、78.5%,2组比较差异有统计学意义(P<0.01);2组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:雷贝拉唑与不同抗生素联用序贯治疗可显著提高Hp的根治率,不良反应发生率低且轻微。 OBJECTIVE:To observe the efficacy of sequential treatment with rabeprazole combined with different antibiotic on Helicobacter pylori(Hp) infection.METHODS:Hp infection was confirmed by the 14C-urea breath test in 186 peptic ulcer or chronic gastritis patients confirmed by gastroscopy.Patients were randomly divided into observation group and the control group with each of 93 cases.Patients in the observation group were treated with tetracycline+clarithromycin+ rabeprazole for 5 days,followed by rabeprazole+levofloxacin+furazolidone for 5 days.The control group was treated with rabeprazole+amoxicillin+clarithromycin for 10 days.14C-urea breath test was carried out 4 weeks later after the treatment was finished.RESULTS:Hp eradication rate of the observation group and control group were 93.5%,78.5%,respectively(P0.01).The incidence of side effects of the 2 groups was not statistically different(P0.05).CONCLUSION:Sequential therapy of rabeprazole combined with different antibiotics can significantly improve the eradication rate of Hp,and show slightly lower incidence of adverse reactions.
作者 李松财
出处 《中国药房》 CAS CSCD 北大核心 2011年第16期1484-1485,共2页 China Pharmacy
关键词 雷贝拉唑 幽门螺杆菌 序贯治疗 Rabeprazole Helicobacter pylori Sequential treatment
  • 相关文献

参考文献7

  • 1李予,王晓艳,沈守荣.4种三联疗法根治幽门螺杆菌的临床疗效观察[J].中南大学学报(医学版),2008,33(12):1129-1131. 被引量:18
  • 2吴玉刚,王莹莹.左氧氟沙星、奥美拉唑、呋喃唑酮三联疗法根治幽门螺杆菌的疗效分析[J].中外医疗,2008,27(20):80-81. 被引量:3
  • 3Graham DY,Shiotani A.New concepts of resistance in the treatment of helieobaeter pylori infections. Nat Cli Pract Gastroenterol Hepatol . 2008
  • 4Gisbert J P,de la Morena F.Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Alimentary Pharmacology and Therapeutics . 2006
  • 5Gen E,Calvet X,Azagra R,et al.Triple vs quadruple therapy for treating Helicobacter pylori infection:an updated meta-analy-sis. Alimentary Pharmacology and Therapeutics . 2003
  • 6Chey WD,Wong BC.American College of Gastroenterology guideline on the management of Helicobacter pylori infection. The American journal of Gastroenterology . 2007
  • 7Cheon JH,Kim N,,Lee DH,et al.Trial of moxifloxacin-containing triple Therapy after initial and second-line treatment failures for helicobacter pylori infection. Korean Journal of Gastroenterology . 2005

二级参考文献17

  • 1张燕捷,吴叔明.幽门螺杆菌耐药性的研究现状[J].上海第二医科大学学报,2005,25(1):93-96. 被引量:19
  • 2Hunt RH,Xiao SD,Megraud F,Leon-Barua R,Bazzoli F,Van der Merwe S,vaz Coelho LG,Fock KM,Fedail S,Cohen H,Malfertheiner P,Vakil N,Hamid S,Goh KL,Wong BC,Krabshuis JH,杜颖,丛衍群,戴宁.世界胃肠病学组织(WGO-OMGE)临床指南——发展中国家幽门螺杆菌感染[J].胃肠病学,2007,12(1):40-52. 被引量:85
  • 3刘爽,崔东来.幽门螺杆菌耐药机制的研究进展[J].国际内科学杂志,2007,34(6):326-329. 被引量:12
  • 4Boyanova L, Mentis A, Gubina M, et al. The status of antimicrobial resistance of Helicobacter pylori in eastern Europe [J]. Clin Microbiol Infect, 2002, 8 (7) : 388-396.
  • 5Perezaldana L, Kato M, Nakagawa S, et al. The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance [ J ] . Helicobacter,2002,7(5) : 306-309.
  • 6Poon S K, Chang C S, Su J, et al. Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole based triple therapies [ J ]. Aliment Pharmacol Ther, 2002,16 (2) : 291-296.
  • 7Soll A H. Medical treatment of pepticulcer disease: practice guidelines[J]. JAMA, 1996, 275(8) :622.
  • 8Stedman C A M, Barclag M L. Review article comparison of the pharm aeokinetics. Acid suppression and efficacy of proton pump inhibitors [ J]. Aliment Pharmacol Ther, 2000, 14 (8) :963-978.
  • 9[2]Georgopoulos SD,Ladas SD,Karatapanis S,et al.Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole,amoxicilin,and clarithromycin[J].Dig Dis Sci,2000,45(1):63~66.
  • 10[3]Hoshiya S,Watanabe K,Tokunaga K,et al.Relationship between eradication'therapy and clarithromycin-resistant Helicobacter pylori in Japan[J].J Gastroenterol,2000,35(1):10~14.

共引文献19

同被引文献76

引证文献9

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部